PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
49.06
ESG score 80-90% of FBIO's 60.88. Walter Schloss would scrutinize governance quality and regulatory exposure.
63.54
Environmental score 1.1-1.2x FBIO's 55.07. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
31.02
Social score below 80% of FBIO's 64.46. Jim Chanos would check for potential social license and litigation risks.
52.63
Governance score 80-90% of FBIO's 63.11. Walter Schloss would scrutinize management accountability and board independence.